Related Experiment Videos

mdmx is a negative regulator of p53 activity in vivo

Rick A Finch1, Dorit B Donoviel, David Potter

  • 1Lexicon Genetics, Inc., 4000 Research Forest Drive, The Woodlands, TX 77381, USA.

Cancer Research
|May 31, 2002
PubMed

Insights

Loss of MDMX, a p53-binding protein, causes embryonic lethality rescued by p53 absence. MDMX negatively regulates p53 protein activity in vivo, impacting embryogenesis and DNA damage response.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • p53 protein activity is crucial for embryogenesis, tumor suppression, and DNA damage response.
  • MDMX is a known p53-binding protein, but its in vivo function remains incompletely understood.

Purpose of the Study:

  • To investigate the in vivo role of MDMX in regulating p53 activity.
  • To determine the consequences of MDMX loss on embryonic development and cellular responses.

Main Methods:

  • Generation and analysis of mdmx and p53 double knockout mice.
  • Phenotypic characterization of embryos and fibroblasts from knockout mice.
  • Assessment of p53 protein levels and target gene expression.

Main Results:

  • Loss of mdmx leads to midgestational embryonic lethality, which is rescued by the absence of p53.
  • Mice lacking both mdmx and p53 are viable and developmentally normal.
  • Fibroblasts with reduced mdmx show decreased growth, increased UV-induced apoptosis, and elevated p53 levels.

Conclusions:

  • MDMX functions as a critical negative regulator of p53 in vivo.
  • The p53-MDMX interaction is essential for normal embryonic development and cellular homeostasis.

Related Concept Videos